Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Probiotics for Vernal Keratoconjunctivitis in Children
NCT06793514Phase 1Not yet recruiting
- Start
- Feb 2025
- Primary completion
- May 2025
01
Overview
Phase 1, randomised, double-blind trial (2 arms). Primary endpoints: Severity of ocular symptoms at 1 month and Alterations of gut microbiota at 1 month. Planned start Feb 2025; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06793514.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06793514.